Cervical cancer (CC) is a gynecological neoplasm with the highest incidence rate, primarily
attributed to the persistent infection of high-risk Human papillomavirus (HPV). Despite …

Background Effective treatment is needed for advanced, inoperable, or chemotherapy-
resistant cervical cancer patients. Immunotherapy has become a new treatment modality for …

Objective This review summarizes women's acceptability of vaginal self-sampling for
cervical cancer screening in Latin America. Study design Systematic review Method A …

Pseudomonas aeruginosa is the most common bacterium occurred in nosocomial infections
and is also an important indicator of food spoilage. The worldwide spread of multidrug …

Almost all cases of cervical cancer (CC) can be attributed to high‐risk human papillomavirus
(HPVs) infections in keratinocytes. However, it is unknown whether HPV invades immune …

High-risk human papillomavirus (hrHPV) infection has been associated with a higher
probability of progression to cervical cancer. However, several extensive studies have …

Background Some high-grade cervical lesions and cervical cancers (HSIL+) test negative for
human papillomavirus (HPV). The HPV-negative fraction varies between 0.03% and 15 …

Objective While human papillomavirus (HPV) has been shown to play a significant role in
cervical cancer carcinogenesis (HPV associated cases), a considerable percentage of …

Human papillomavirus (HPV) negative cancers are associated with symptomatic detection,
late-stage diagnosis, and worse prognosis. It is thus essential to investigate all possible …

Herein, A non-invasive pathomics approach was developed to reveal the methylation status
in patients with cervical squamous cell carcinoma and predict clinical outcomes and …